Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP914253.RAZVansMMzQMF5urma_396xlBlPinzR0ssXD_ja26Xuik130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914253.RAZVansMMzQMF5urma_396xlBlPinzR0ssXD_ja26Xuik130_provenance.
• NP606217.RARxDKkq-UTj4hEc_Q4jmS5voPMERrPn9H0HMYJB0Dixs130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606217.RARxDKkq-UTj4hEc_Q4jmS5voPMERrPn9H0HMYJB0Dixs130_provenance.
• NP978716.RAZ1k1O2WKIAHHcLJUAPXWOk7fsQdWUdorgy3lA6dLbWY130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978716.RAZ1k1O2WKIAHHcLJUAPXWOk7fsQdWUdorgy3lA6dLbWY130_provenance.
• assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP857873.RAtt3lAdayGhf7_WrlwmYc04E2OMVmvesJdzgcoZIwRcY130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857873.RAtt3lAdayGhf7_WrlwmYc04E2OMVmvesJdzgcoZIwRcY130_provenance.
• NP857950.RAlipFJzg91zUWT4FTacKHPeaoQ0xSHolYXHr3FO0yKdM130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857950.RAlipFJzg91zUWT4FTacKHPeaoQ0xSHolYXHr3FO0yKdM130_provenance.
• NP999922.RAYUB_P2Al8M4YKsXxZgZvsIwvY01OdAQCCAjeJe7NUGc130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999922.RAYUB_P2Al8M4YKsXxZgZvsIwvY01OdAQCCAjeJe7NUGc130_provenance.
• NP999929.RAU9OKAoLoSD1CTtsfKPqncYWJdv-fyw6rVn3BgUbrTTQ130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999929.RAU9OKAoLoSD1CTtsfKPqncYWJdv-fyw6rVn3BgUbrTTQ130_provenance.
• NP999931.RAe_1jlt7vQyJ9kGQoskpFbDPC-BkdrczQpVFlmO8OEpY130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999931.RAe_1jlt7vQyJ9kGQoskpFbDPC-BkdrczQpVFlmO8OEpY130_provenance.
• NP873061.RApMXqPiLezOew3Q4tppJYZI8Sk6opEMylYdxh4AIzb28130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873061.RApMXqPiLezOew3Q4tppJYZI8Sk6opEMylYdxh4AIzb28130_provenance.
• NP913891.RAgK8uuUqdyCgGTxrUqZb265wl5X7EskDQb74oL8o1I_A130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913891.RAgK8uuUqdyCgGTxrUqZb265wl5X7EskDQb74oL8o1I_A130_provenance.
• NP999926.RAmuPaHmvqzZRsNrmvfYagMBDrmZqtgsyC6GDpWuRfkuI130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999926.RAmuPaHmvqzZRsNrmvfYagMBDrmZqtgsyC6GDpWuRfkuI130_provenance.
• NP999927.RAkZLPz4KsKWKhW4xQetQx0afVifKDu0Ke9E3I-9v6fLQ130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999927.RAkZLPz4KsKWKhW4xQetQx0afVifKDu0Ke9E3I-9v6fLQ130_provenance.
• NP999928.RAi1Lu6VIq9PpTMzAbG3bB6W5Dcn775zUnLrsoVLicRhI130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999928.RAi1Lu6VIq9PpTMzAbG3bB6W5Dcn775zUnLrsoVLicRhI130_provenance.
• NP999933.RAmOB6tWnGZC_oAlqwCVLcqF92qc_q2i9Q0v-eaLBLCCg130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999933.RAmOB6tWnGZC_oAlqwCVLcqF92qc_q2i9Q0v-eaLBLCCg130_provenance.
• NP605864.RA_n62rNGSCc9I1p93wLRXyv1FLL52EcwvvJVFxfHsF9I130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605864.RA_n62rNGSCc9I1p93wLRXyv1FLL52EcwvvJVFxfHsF9I130_provenance.
• NP605992.RA8ph-JSuW1Yf86J81OAFeNwMVaO7pFkyhhVacA20mwFM130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605992.RA8ph-JSuW1Yf86J81OAFeNwMVaO7pFkyhhVacA20mwFM130_provenance.
• NP781436.RAGUup8jafNuoBlf_afUIP4xde1_WTaMH2NINhR8Esbaw130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781436.RAGUup8jafNuoBlf_afUIP4xde1_WTaMH2NINhR8Esbaw130_provenance.
• NP781631.RAIXs1zOLzi13GmJIP9P8nhxLqlJQWnA75hDK6QrMDThU130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781631.RAIXs1zOLzi13GmJIP9P8nhxLqlJQWnA75hDK6QrMDThU130_provenance.
• NP999921.RAP_DAI_OJ7ZzCIKHtG200oYTDr_UVgGAZ1vyE4MnLbLE130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999921.RAP_DAI_OJ7ZzCIKHtG200oYTDr_UVgGAZ1vyE4MnLbLE130_provenance.
• NP999930.RAFuKLlUJ_R4t00F_qGQ9ydlGddeaD08Z6KMklJGQSRDs130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999930.RAFuKLlUJ_R4t00F_qGQ9ydlGddeaD08Z6KMklJGQSRDs130_provenance.
• NP873366.RAHFgxbnyWzpwf3W67b1UY2Ki1LwP7R5i5_NWXaeAgrm8130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873366.RAHFgxbnyWzpwf3W67b1UY2Ki1LwP7R5i5_NWXaeAgrm8130_provenance.
• NP781312.RA00qnZQ2QHRnNMGwMhwr6DDIAohUaRoN-jUwUIiVpD5c130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781312.RA00qnZQ2QHRnNMGwMhwr6DDIAohUaRoN-jUwUIiVpD5c130_provenance.
• NP978402.RAwK99ci_0MMio8V9BDebEY2rcN2bhrYEy9z2MXr5SlhU130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978402.RAwK99ci_0MMio8V9BDebEY2rcN2bhrYEy9z2MXr5SlhU130_provenance.
• NP999920.RA6lhlmm2tUHuQjjuRtG2lZnH_i9TV_wvawoi_Hy35A0w130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999920.RA6lhlmm2tUHuQjjuRtG2lZnH_i9TV_wvawoi_Hy35A0w130_provenance.
• NP999924.RA2AFpppdB2uWDIzoBkLSVdy2_XeayUu5CDy5XTbkpz3k130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999924.RA2AFpppdB2uWDIzoBkLSVdy2_XeayUu5CDy5XTbkpz3k130_provenance.
• NP999925.RA5eExRhRf3-MEin1aswlJTI1MdT5GiPnXCYtAULKpNs8130_assertion description "[SF3B1, splicing factor 3b subunit 1 is mutated in 60%-80% of refractory anemia with ring sideroblasts (RARS) and RARS associated with thrombocytosis (RARS-T), 2 distinct subtypes of MDS and MDS/myeloproliferative neoplasms (MDSs/MPNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999925.RA5eExRhRf3-MEin1aswlJTI1MdT5GiPnXCYtAULKpNs8130_provenance.